[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)]
S Nguyen1, D Blaise2, J-O Bay3
1Service d'hématologie, G.H. Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France.
Insights
Haploidentical allogeneic stem cell transplantation is a growing alternative to other stem cell sources. Further research is needed to confirm its role in routine patient care, with ongoing efforts to standardize practices.
Area of Science:
- Hematology
- Transplantation immunology
- Cell therapy
Context:
- Haploidentical allogeneic stem cell transplantation (CST) has gained significant traction globally over the last ten years.
- It presents a viable alternative to conventional stem cell sources.
- Standardization of clinical practices across different French transplantation centers is an ongoing objective.
Purpose:
- To harmonize clinical practices for haploidentical allogeneic stem cell transplantation (CST) among French centers.
- To present part two of the recommendations for allogeneic stem cell transplantation from an HLA-haploidentical related donor.
- To facilitate discussion and consensus among practitioners at the SFGM-TC workshops.
Summary:
- The French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC) convened its fourth annual workshop in Lille, September 2013.
- Practitioners from SFGM-TC member centers collaborated to discuss and refine recommendations for CST.
- This part two focuses specifically on allogeneic transplantation using HLA-haploidentical related donors.
Impact:
- Aims to establish standardized protocols for haploidentical CST, potentially improving patient outcomes.
- Contributes to the validation of CST as a standard care option.
- Fosters collaboration and knowledge exchange within the French transplantation community.
Abstract:
Haploidentical allogeneic stem cell transplantation (CST) has globally taken off in the past decade. It appears to be a valid alternative to other sources of stem cells; however, further research is necessary to validate the use of this approach in standard patient care. In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC) set up its fourth annual series of workshops which brought together practitioners from all of its member centers. These workshops took place in September 2013 in Lille. This is part two of the recommendations regarding allogeneic stem cell transplantation from an HLA-haploidentical related donor.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...


